Differential Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stromal Cells on Natural Killer Cells-Reference-Cited by-同舟云学术

Differential Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stromal Cells on Natural Killer Cells

Published:2019-07-15 Issue:14 Volume:28 Page:933-943
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Hu Chia-Hsuan Donna¹,Kosaka Yoko¹,Marcus Paula¹,Rashedi Iran¹,Keating Armand¹

Affiliation:

1. Cell Therapy Translational Research Laboratory, Princess Margaret Cancer Center, Krembil Research Institute, University Health Network, Toronto, ON, Canada

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2019.0059

Reference49 articles.

1. Mesenchymal Stromal Cells: New Directions

2. Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views

3. Mesenchymal stem cells in health and disease

4. Immunoregulation by Mesenchymal Stem Cells: Biological Aspects and Clinical Applications

5. Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in diabetic foot ulcer research: Focus on mesenchymal stem cells and their exosomes;Heliyon;2024-09

2. Advances and clinical challenges of mesenchymal stem cell therapy;Frontiers in Immunology;2024-07-19

3. Local delivery of stem cell spheroids with protein/polyphenol self-assembling armor to improve myocardial infarction treatment via immunoprotection and immunoregulation;Biomaterials;2024-06

4. The Mechanisms of Mesenchymal Stem Cells in the Treatment of Experimental Autoimmune Encephalomyelitis;Current Stem Cell Research & Therapy;2024-05-20

5. International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges;Cytotherapy;2024-05